Partnership
OUR APPROACH TO RESEARCH
Our approach to R&D includes monitoring epidemiological statistics and conducting pharmacoeconomic analysis of the healthcare systems in Russia and CIS countries, as well as studying international research. We rigorously assess the efficacy and safety of the drugs considered for inclusion in our portfolio. The products we select undergo preclinical and clinical trials in target markets, as well as testing as part of the state registration of new products.
"Pharm Aid" is committed to providing the Russian and CIS markets with best-in-class innovative biotechnological products.
We continuously explore new drugs, biotechnologies, medical devices, diagnostics, and more emerging in the global market. If you have an innovative product or solution that opens new horizons in pharmaceuticals or medicine but is not yet available in our target markets, we would be happy to discuss potential collaboration opportunities with you.
